nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—ANKK1—alcohol dependence	0.698	1	CbGaD
Ruxolitinib—Tuberculosis—Citalopram—alcohol dependence	0.00633	0.0874	CcSEcCtD
Ruxolitinib—Night sweats—Naltrexone—alcohol dependence	0.00338	0.0467	CcSEcCtD
Ruxolitinib—Night sweats—Citalopram—alcohol dependence	0.00214	0.0296	CcSEcCtD
Ruxolitinib—Hypercholesterolaemia—Naltrexone—alcohol dependence	0.00193	0.0266	CcSEcCtD
Ruxolitinib—Herpes zoster—Citalopram—alcohol dependence	0.00153	0.0212	CcSEcCtD
Ruxolitinib—Gastrointestinal haemorrhage—Acamprosate—alcohol dependence	0.0014	0.0193	CcSEcCtD
Ruxolitinib—Contusion—Citalopram—alcohol dependence	0.00132	0.0183	CcSEcCtD
Ruxolitinib—Gastrointestinal haemorrhage—Naltrexone—alcohol dependence	0.00132	0.0183	CcSEcCtD
Ruxolitinib—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00123	0.017	CcSEcCtD
Ruxolitinib—Hypercholesterolaemia—Citalopram—alcohol dependence	0.00122	0.0169	CcSEcCtD
Ruxolitinib—Bone pain—Citalopram—alcohol dependence	0.00121	0.0167	CcSEcCtD
Ruxolitinib—Fatigue—Disulfiram—alcohol dependence	0.0012	0.0166	CcSEcCtD
Ruxolitinib—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.00117	0.0161	CcSEcCtD
Ruxolitinib—Weight increased—Acamprosate—alcohol dependence	0.0011	0.0152	CcSEcCtD
Ruxolitinib—Weight decreased—Acamprosate—alcohol dependence	0.00109	0.0151	CcSEcCtD
Ruxolitinib—Urinary tract infection—Acamprosate—alcohol dependence	0.00105	0.0145	CcSEcCtD
Ruxolitinib—Weight increased—Naltrexone—alcohol dependence	0.00104	0.0144	CcSEcCtD
Ruxolitinib—Weight decreased—Naltrexone—alcohol dependence	0.00104	0.0143	CcSEcCtD
Ruxolitinib—Haematuria—Acamprosate—alcohol dependence	0.00103	0.0142	CcSEcCtD
Ruxolitinib—Infestation—Naltrexone—alcohol dependence	0.00102	0.0141	CcSEcCtD
Ruxolitinib—Infestation NOS—Naltrexone—alcohol dependence	0.00102	0.0141	CcSEcCtD
Ruxolitinib—Epistaxis—Acamprosate—alcohol dependence	0.00102	0.014	CcSEcCtD
Ruxolitinib—Asthenia—Disulfiram—alcohol dependence	0.001	0.0138	CcSEcCtD
Ruxolitinib—Urinary tract infection—Naltrexone—alcohol dependence	0.000992	0.0137	CcSEcCtD
Ruxolitinib—Haemoglobin—Acamprosate—alcohol dependence	0.000973	0.0134	CcSEcCtD
Ruxolitinib—Haemorrhage—Acamprosate—alcohol dependence	0.000968	0.0134	CcSEcCtD
Ruxolitinib—Hepatobiliary disease—Naltrexone—alcohol dependence	0.000965	0.0133	CcSEcCtD
Ruxolitinib—Epistaxis—Naltrexone—alcohol dependence	0.000963	0.0133	CcSEcCtD
Ruxolitinib—Dizziness—Disulfiram—alcohol dependence	0.000923	0.0127	CcSEcCtD
Ruxolitinib—Headache—Disulfiram—alcohol dependence	0.000875	0.0121	CcSEcCtD
Ruxolitinib—Malnutrition—Acamprosate—alcohol dependence	0.000843	0.0116	CcSEcCtD
Ruxolitinib—Gastrointestinal haemorrhage—Citalopram—alcohol dependence	0.000839	0.0116	CcSEcCtD
Ruxolitinib—Flatulence—Acamprosate—alcohol dependence	0.000831	0.0115	CcSEcCtD
Ruxolitinib—Malnutrition—Naltrexone—alcohol dependence	0.000797	0.011	CcSEcCtD
Ruxolitinib—Flatulence—Naltrexone—alcohol dependence	0.000786	0.0108	CcSEcCtD
Ruxolitinib—Anaemia—Acamprosate—alcohol dependence	0.000779	0.0108	CcSEcCtD
Ruxolitinib—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.00074	0.0102	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000713	0.00984	CcSEcCtD
Ruxolitinib—Pancytopenia—Citalopram—alcohol dependence	0.000689	0.00951	CcSEcCtD
Ruxolitinib—Infection—Acamprosate—alcohol dependence	0.000683	0.00943	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000674	0.00931	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Acamprosate—alcohol dependence	0.000674	0.0093	CcSEcCtD
Ruxolitinib—Skin disorder—Acamprosate—alcohol dependence	0.000668	0.00922	CcSEcCtD
Ruxolitinib—Weight increased—Citalopram—alcohol dependence	0.00066	0.00911	CcSEcCtD
Ruxolitinib—Weight decreased—Citalopram—alcohol dependence	0.000656	0.00906	CcSEcCtD
Ruxolitinib—Infection—Naltrexone—alcohol dependence	0.000647	0.00893	CcSEcCtD
Ruxolitinib—Infestation NOS—Citalopram—alcohol dependence	0.000647	0.00893	CcSEcCtD
Ruxolitinib—Infestation—Citalopram—alcohol dependence	0.000647	0.00893	CcSEcCtD
Ruxolitinib—Nervous system disorder—Naltrexone—alcohol dependence	0.000638	0.00881	CcSEcCtD
Ruxolitinib—Skin disorder—Naltrexone—alcohol dependence	0.000632	0.00873	CcSEcCtD
Ruxolitinib—Urinary tract infection—Citalopram—alcohol dependence	0.000628	0.00868	CcSEcCtD
Ruxolitinib—Haematuria—Citalopram—alcohol dependence	0.000616	0.00851	CcSEcCtD
Ruxolitinib—Hepatobiliary disease—Citalopram—alcohol dependence	0.000612	0.00844	CcSEcCtD
Ruxolitinib—Epistaxis—Citalopram—alcohol dependence	0.00061	0.00842	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000594	0.0082	CcSEcCtD
Ruxolitinib—Haemoglobin—Citalopram—alcohol dependence	0.000583	0.00805	CcSEcCtD
Ruxolitinib—Haemorrhage—Citalopram—alcohol dependence	0.00058	0.00801	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000562	0.00776	CcSEcCtD
Ruxolitinib—Fatigue—Naltrexone—alcohol dependence	0.000561	0.00775	CcSEcCtD
Ruxolitinib—Body temperature increased—Acamprosate—alcohol dependence	0.000544	0.00751	CcSEcCtD
Ruxolitinib—Body temperature increased—Naltrexone—alcohol dependence	0.000515	0.0071	CcSEcCtD
Ruxolitinib—Malnutrition—Citalopram—alcohol dependence	0.000505	0.00698	CcSEcCtD
Ruxolitinib—Flatulence—Citalopram—alcohol dependence	0.000498	0.00687	CcSEcCtD
Ruxolitinib—Asthenia—Acamprosate—alcohol dependence	0.000494	0.00681	CcSEcCtD
Ruxolitinib—Pruritus—Acamprosate—alcohol dependence	0.000487	0.00672	CcSEcCtD
Ruxolitinib—Anaemia—Citalopram—alcohol dependence	0.000467	0.00645	CcSEcCtD
Ruxolitinib—Asthenia—Naltrexone—alcohol dependence	0.000467	0.00645	CcSEcCtD
Ruxolitinib—Pruritus—Naltrexone—alcohol dependence	0.00046	0.00636	CcSEcCtD
Ruxolitinib—Dizziness—Acamprosate—alcohol dependence	0.000455	0.00628	CcSEcCtD
Ruxolitinib—Headache—Acamprosate—alcohol dependence	0.000431	0.00595	CcSEcCtD
Ruxolitinib—Dizziness—Naltrexone—alcohol dependence	0.00043	0.00594	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000427	0.0059	CcSEcCtD
Ruxolitinib—Infection—Citalopram—alcohol dependence	0.00041	0.00566	CcSEcCtD
Ruxolitinib—Headache—Naltrexone—alcohol dependence	0.000408	0.00563	CcSEcCtD
Ruxolitinib—Nervous system disorder—Citalopram—alcohol dependence	0.000404	0.00558	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Citalopram—alcohol dependence	0.000404	0.00557	CcSEcCtD
Ruxolitinib—Skin disorder—Citalopram—alcohol dependence	0.000401	0.00553	CcSEcCtD
Ruxolitinib—MAP3K7—adrenal cortex—alcohol dependence	0.000399	0.00283	CbGeAlD
Ruxolitinib—CAMK1—cerebellum—alcohol dependence	0.000398	0.00282	CbGeAlD
Ruxolitinib—MARK2—central nervous system—alcohol dependence	0.000396	0.0028	CbGeAlD
Ruxolitinib—CAMK2G—pancreas—alcohol dependence	0.000393	0.00279	CbGeAlD
Ruxolitinib—DCLK3—brain—alcohol dependence	0.000393	0.00278	CbGeAlD
Ruxolitinib—TYK2—adrenal cortex—alcohol dependence	0.000392	0.00278	CbGeAlD
Ruxolitinib—TAOK2—testis—alcohol dependence	0.000387	0.00274	CbGeAlD
Ruxolitinib—MKNK2—adrenal cortex—alcohol dependence	0.000387	0.00274	CbGeAlD
Ruxolitinib—MARK2—cerebellum—alcohol dependence	0.000387	0.00274	CbGeAlD
Ruxolitinib—ROCK1—digestive system—alcohol dependence	0.000387	0.00274	CbGeAlD
Ruxolitinib—JAK2—forebrain—alcohol dependence	0.000385	0.00273	CbGeAlD
Ruxolitinib—DAPK3—blood—alcohol dependence	0.000384	0.00272	CbGeAlD
Ruxolitinib—CLK2—blood—alcohol dependence	0.00038	0.00269	CbGeAlD
Ruxolitinib—DAPK3—midbrain—alcohol dependence	0.000379	0.00268	CbGeAlD
Ruxolitinib—BMPR2—digestive system—alcohol dependence	0.000376	0.00266	CbGeAlD
Ruxolitinib—JAK3—endocrine gland—alcohol dependence	0.000373	0.00264	CbGeAlD
Ruxolitinib—JAK1—endocrine gland—alcohol dependence	0.000371	0.00263	CbGeAlD
Ruxolitinib—DCLK1—endocrine gland—alcohol dependence	0.000371	0.00263	CbGeAlD
Ruxolitinib—PLK4—endocrine gland—alcohol dependence	0.000369	0.00261	CbGeAlD
Ruxolitinib—ROCK1—blood—alcohol dependence	0.000368	0.00261	CbGeAlD
Ruxolitinib—BMP2K—gonad—alcohol dependence	0.000367	0.0026	CbGeAlD
Ruxolitinib—TAOK2—liver—alcohol dependence	0.000366	0.00259	CbGeAlD
Ruxolitinib—LRRK2—gonad—alcohol dependence	0.000364	0.00258	CbGeAlD
Ruxolitinib—CAMK1D—endocrine gland—alcohol dependence	0.000362	0.00256	CbGeAlD
Ruxolitinib—PHKG2—endocrine gland—alcohol dependence	0.00036	0.00255	CbGeAlD
Ruxolitinib—TAOK2—cerebellum—alcohol dependence	0.000358	0.00253	CbGeAlD
Ruxolitinib—TYK2—cardiovascular system—alcohol dependence	0.000358	0.00253	CbGeAlD
Ruxolitinib—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000356	0.00491	CcSEcCtD
Ruxolitinib—JAK3—testis—alcohol dependence	0.000356	0.00252	CbGeAlD
Ruxolitinib—Fatigue—Citalopram—alcohol dependence	0.000356	0.00491	CcSEcCtD
Ruxolitinib—JAK1—testis—alcohol dependence	0.000354	0.00251	CbGeAlD
Ruxolitinib—DCLK1—testis—alcohol dependence	0.000354	0.00251	CbGeAlD
Ruxolitinib—BMPR2—midbrain—alcohol dependence	0.000353	0.0025	CbGeAlD
Ruxolitinib—MKNK2—cardiovascular system—alcohol dependence	0.000353	0.0025	CbGeAlD
Ruxolitinib—PLK4—testis—alcohol dependence	0.000352	0.00249	CbGeAlD
Ruxolitinib—TAOK3—brainstem—alcohol dependence	0.00035	0.00248	CbGeAlD
Ruxolitinib—JAK3—nervous system—alcohol dependence	0.000349	0.00248	CbGeAlD
Ruxolitinib—STK16—endocrine gland—alcohol dependence	0.000348	0.00247	CbGeAlD
Ruxolitinib—TYK2—pancreas—alcohol dependence	0.000348	0.00246	CbGeAlD
Ruxolitinib—DCLK1—nervous system—alcohol dependence	0.000347	0.00246	CbGeAlD
Ruxolitinib—JAK1—nervous system—alcohol dependence	0.000347	0.00246	CbGeAlD
Ruxolitinib—HIPK2—endocrine gland—alcohol dependence	0.000346	0.00245	CbGeAlD
Ruxolitinib—PLK3—brain—alcohol dependence	0.000346	0.00245	CbGeAlD
Ruxolitinib—CAMK1D—testis—alcohol dependence	0.000345	0.00245	CbGeAlD
Ruxolitinib—MAP3K3—adrenal cortex—alcohol dependence	0.000344	0.00243	CbGeAlD
Ruxolitinib—PHKG2—testis—alcohol dependence	0.000343	0.00243	CbGeAlD
Ruxolitinib—IRAK1—pancreas—alcohol dependence	0.000343	0.00243	CbGeAlD
Ruxolitinib—MKNK2—pancreas—alcohol dependence	0.000343	0.00243	CbGeAlD
Ruxolitinib—NUAK2—blood—alcohol dependence	0.000342	0.00242	CbGeAlD
Ruxolitinib—CAMK1D—nervous system—alcohol dependence	0.000339	0.0024	CbGeAlD
Ruxolitinib—TAOK3—forebrain—alcohol dependence	0.000338	0.0024	CbGeAlD
Ruxolitinib—DAPK2—testis—alcohol dependence	0.000337	0.00239	CbGeAlD
Ruxolitinib—PHKG2—nervous system—alcohol dependence	0.000337	0.00239	CbGeAlD
Ruxolitinib—JAK3—central nervous system—alcohol dependence	0.000336	0.00238	CbGeAlD
Ruxolitinib—CAMK2G—digestive system—alcohol dependence	0.000336	0.00238	CbGeAlD
Ruxolitinib—JAK1—liver—alcohol dependence	0.000334	0.00237	CbGeAlD
Ruxolitinib—JAK1—central nervous system—alcohol dependence	0.000334	0.00237	CbGeAlD
Ruxolitinib—DCLK1—central nervous system—alcohol dependence	0.000334	0.00237	CbGeAlD
Ruxolitinib—LTK—brain—alcohol dependence	0.000334	0.00237	CbGeAlD
Ruxolitinib—MAP3K2—gonad—alcohol dependence	0.000334	0.00236	CbGeAlD
Ruxolitinib—DAPK3—endocrine gland—alcohol dependence	0.000333	0.00236	CbGeAlD
Ruxolitinib—STK16—testis—alcohol dependence	0.000332	0.00235	CbGeAlD
Ruxolitinib—HIPK2—testis—alcohol dependence	0.00033	0.00234	CbGeAlD
Ruxolitinib—CLK2—endocrine gland—alcohol dependence	0.00033	0.00233	CbGeAlD
Ruxolitinib—JAK3—cerebellum—alcohol dependence	0.000329	0.00233	CbGeAlD
Ruxolitinib—JAK1—cerebellum—alcohol dependence	0.000327	0.00231	CbGeAlD
Ruxolitinib—DCLK1—cerebellum—alcohol dependence	0.000327	0.00231	CbGeAlD
Ruxolitinib—CAMK1D—liver—alcohol dependence	0.000326	0.00231	CbGeAlD
Ruxolitinib—CAMK1D—central nervous system—alcohol dependence	0.000326	0.00231	CbGeAlD
Ruxolitinib—Body temperature increased—Citalopram—alcohol dependence	0.000326	0.0045	CcSEcCtD
Ruxolitinib—STK16—nervous system—alcohol dependence	0.000326	0.00231	CbGeAlD
Ruxolitinib—JAK2—cardiovascular system—alcohol dependence	0.000325	0.0023	CbGeAlD
Ruxolitinib—PHKG2—liver—alcohol dependence	0.000325	0.0023	CbGeAlD
Ruxolitinib—PHKG2—central nervous system—alcohol dependence	0.000324	0.0023	CbGeAlD
Ruxolitinib—HIPK2—nervous system—alcohol dependence	0.000324	0.0023	CbGeAlD
Ruxolitinib—MAP3K19—testis—alcohol dependence	0.000324	0.00229	CbGeAlD
Ruxolitinib—CAMK1—brain—alcohol dependence	0.000324	0.00229	CbGeAlD
Ruxolitinib—MKNK2—gonad—alcohol dependence	0.00032	0.00227	CbGeAlD
Ruxolitinib—CAMK2G—blood—alcohol dependence	0.00032	0.00227	CbGeAlD
Ruxolitinib—BMP2K—blood—alcohol dependence	0.00032	0.00227	CbGeAlD
Ruxolitinib—ROCK1—endocrine gland—alcohol dependence	0.000319	0.00226	CbGeAlD
Ruxolitinib—CAMK1D—cerebellum—alcohol dependence	0.000319	0.00226	CbGeAlD
Ruxolitinib—MAP3K19—nervous system—alcohol dependence	0.000318	0.00225	CbGeAlD
Ruxolitinib—DAPK3—testis—alcohol dependence	0.000317	0.00225	CbGeAlD
Ruxolitinib—LRRK2—blood—alcohol dependence	0.000317	0.00225	CbGeAlD
Ruxolitinib—PHKG2—cerebellum—alcohol dependence	0.000317	0.00225	CbGeAlD
Ruxolitinib—CAMK2G—midbrain—alcohol dependence	0.000316	0.00224	CbGeAlD
Ruxolitinib—BMP2K—midbrain—alcohol dependence	0.000316	0.00224	CbGeAlD
Ruxolitinib—CLK2—testis—alcohol dependence	0.000314	0.00223	CbGeAlD
Ruxolitinib—MARK2—brain—alcohol dependence	0.000314	0.00222	CbGeAlD
Ruxolitinib—STK16—liver—alcohol dependence	0.000314	0.00222	CbGeAlD
Ruxolitinib—STK16—central nervous system—alcohol dependence	0.000314	0.00222	CbGeAlD
Ruxolitinib—MAP3K3—cardiovascular system—alcohol dependence	0.000314	0.00222	CbGeAlD
Ruxolitinib—LRRK2—midbrain—alcohol dependence	0.000313	0.00222	CbGeAlD
Ruxolitinib—TAOK3—adrenal cortex—alcohol dependence	0.000313	0.00222	CbGeAlD
Ruxolitinib—HIPK2—liver—alcohol dependence	0.000312	0.00221	CbGeAlD
Ruxolitinib—HIPK2—central nervous system—alcohol dependence	0.000312	0.00221	CbGeAlD
Ruxolitinib—DAPK2—cerebellum—alcohol dependence	0.000312	0.00221	CbGeAlD
Ruxolitinib—DYRK1A—endocrine gland—alcohol dependence	0.000312	0.00221	CbGeAlD
Ruxolitinib—DAPK3—nervous system—alcohol dependence	0.000311	0.00221	CbGeAlD
Ruxolitinib—BMPR2—endocrine gland—alcohol dependence	0.00031	0.0022	CbGeAlD
Ruxolitinib—CLK2—nervous system—alcohol dependence	0.000308	0.00219	CbGeAlD
Ruxolitinib—STK16—cerebellum—alcohol dependence	0.000307	0.00217	CbGeAlD
Ruxolitinib—MAP3K19—central nervous system—alcohol dependence	0.000306	0.00217	CbGeAlD
Ruxolitinib—HIPK2—cerebellum—alcohol dependence	0.000305	0.00216	CbGeAlD
Ruxolitinib—ROCK1—testis—alcohol dependence	0.000305	0.00216	CbGeAlD
Ruxolitinib—DAPK3—liver—alcohol dependence	0.0003	0.00213	CbGeAlD
Ruxolitinib—DAPK3—central nervous system—alcohol dependence	0.0003	0.00212	CbGeAlD
Ruxolitinib—ROCK1—nervous system—alcohol dependence	0.000299	0.00212	CbGeAlD
Ruxolitinib—CLK2—liver—alcohol dependence	0.000297	0.00211	CbGeAlD
Ruxolitinib—DYRK1A—testis—alcohol dependence	0.000297	0.0021	CbGeAlD
Ruxolitinib—CLK2—central nervous system—alcohol dependence	0.000297	0.0021	CbGeAlD
Ruxolitinib—TYK2—digestive system—alcohol dependence	0.000297	0.0021	CbGeAlD
Ruxolitinib—BMPR2—testis—alcohol dependence	0.000296	0.0021	CbGeAlD
Ruxolitinib—Asthenia—Citalopram—alcohol dependence	0.000296	0.00408	CcSEcCtD
Ruxolitinib—JAK2—gonad—alcohol dependence	0.000295	0.00209	CbGeAlD
Ruxolitinib—DAPK3—cerebellum—alcohol dependence	0.000293	0.00208	CbGeAlD
Ruxolitinib—MKNK2—digestive system—alcohol dependence	0.000293	0.00208	CbGeAlD
Ruxolitinib—Pruritus—Citalopram—alcohol dependence	0.000292	0.00403	CcSEcCtD
Ruxolitinib—DYRK1A—nervous system—alcohol dependence	0.000292	0.00207	CbGeAlD
Ruxolitinib—MAP3K2—blood—alcohol dependence	0.000291	0.00206	CbGeAlD
Ruxolitinib—TAOK2—brain—alcohol dependence	0.000291	0.00206	CbGeAlD
Ruxolitinib—BMPR2—nervous system—alcohol dependence	0.00029	0.00206	CbGeAlD
Ruxolitinib—CLK2—cerebellum—alcohol dependence	0.00029	0.00206	CbGeAlD
Ruxolitinib—ROCK1—liver—alcohol dependence	0.000288	0.00204	CbGeAlD
Ruxolitinib—MAP3K7—blood—alcohol dependence	0.000288	0.00204	CbGeAlD
Ruxolitinib—ROCK1—central nervous system—alcohol dependence	0.000288	0.00204	CbGeAlD
Ruxolitinib—TAOK3—cardiovascular system—alcohol dependence	0.000286	0.00203	CbGeAlD
Ruxolitinib—RET—digestive system—alcohol dependence	0.000286	0.00202	CbGeAlD
Ruxolitinib—MAP3K3—gonad—alcohol dependence	0.000285	0.00202	CbGeAlD
Ruxolitinib—MAP3K7—midbrain—alcohol dependence	0.000284	0.00201	CbGeAlD
Ruxolitinib—NUAK2—testis—alcohol dependence	0.000283	0.002	CbGeAlD
Ruxolitinib—TYK2—blood—alcohol dependence	0.000283	0.002	CbGeAlD
Ruxolitinib—DYRK1A—liver—alcohol dependence	0.000281	0.00199	CbGeAlD
Ruxolitinib—DYRK1A—central nervous system—alcohol dependence	0.000281	0.00199	CbGeAlD
Ruxolitinib—BMPR2—liver—alcohol dependence	0.00028	0.00198	CbGeAlD
Ruxolitinib—BMPR2—central nervous system—alcohol dependence	0.00028	0.00198	CbGeAlD
Ruxolitinib—TYK2—midbrain—alcohol dependence	0.000279	0.00198	CbGeAlD
Ruxolitinib—MKNK2—blood—alcohol dependence	0.000279	0.00198	CbGeAlD
Ruxolitinib—IRAK1—blood—alcohol dependence	0.000279	0.00198	CbGeAlD
Ruxolitinib—TAOK3—pancreas—alcohol dependence	0.000278	0.00197	CbGeAlD
Ruxolitinib—CAMK2G—endocrine gland—alcohol dependence	0.000278	0.00197	CbGeAlD
Ruxolitinib—BMP2K—endocrine gland—alcohol dependence	0.000278	0.00197	CbGeAlD
Ruxolitinib—IRAK1—midbrain—alcohol dependence	0.000276	0.00195	CbGeAlD
Ruxolitinib—MKNK2—midbrain—alcohol dependence	0.000276	0.00195	CbGeAlD
Ruxolitinib—LRRK2—endocrine gland—alcohol dependence	0.000275	0.00195	CbGeAlD
Ruxolitinib—DYRK1A—cerebellum—alcohol dependence	0.000274	0.00194	CbGeAlD
Ruxolitinib—BMPR2—cerebellum—alcohol dependence	0.000273	0.00194	CbGeAlD
Ruxolitinib—Dizziness—Citalopram—alcohol dependence	0.000273	0.00376	CcSEcCtD
Ruxolitinib—RET—blood—alcohol dependence	0.000272	0.00193	CbGeAlD
Ruxolitinib—JAK2—digestive system—alcohol dependence	0.00027	0.00191	CbGeAlD
Ruxolitinib—RET—midbrain—alcohol dependence	0.000269	0.0019	CbGeAlD
Ruxolitinib—NUAK2—liver—alcohol dependence	0.000267	0.00189	CbGeAlD
Ruxolitinib—JAK3—brain—alcohol dependence	0.000267	0.00189	CbGeAlD
Ruxolitinib—DCLK1—brain—alcohol dependence	0.000265	0.00188	CbGeAlD
Ruxolitinib—JAK1—brain—alcohol dependence	0.000265	0.00188	CbGeAlD
Ruxolitinib—CAMK2G—testis—alcohol dependence	0.000265	0.00188	CbGeAlD
Ruxolitinib—BMP2K—testis—alcohol dependence	0.000265	0.00188	CbGeAlD
Ruxolitinib—PLK4—brain—alcohol dependence	0.000264	0.00187	CbGeAlD
Ruxolitinib—LRRK2—testis—alcohol dependence	0.000262	0.00186	CbGeAlD
Ruxolitinib—NUAK2—cerebellum—alcohol dependence	0.000261	0.00185	CbGeAlD
Ruxolitinib—CAMK2G—nervous system—alcohol dependence	0.00026	0.00184	CbGeAlD
Ruxolitinib—BMP2K—nervous system—alcohol dependence	0.00026	0.00184	CbGeAlD
Ruxolitinib—CAMK1D—brain—alcohol dependence	0.000259	0.00183	CbGeAlD
Ruxolitinib—Headache—Citalopram—alcohol dependence	0.000258	0.00357	CcSEcCtD
Ruxolitinib—LRRK2—nervous system—alcohol dependence	0.000258	0.00182	CbGeAlD
Ruxolitinib—PHKG2—brain—alcohol dependence	0.000258	0.00182	CbGeAlD
Ruxolitinib—JAK2—blood—alcohol dependence	0.000257	0.00182	CbGeAlD
Ruxolitinib—DAPK2—brain—alcohol dependence	0.000253	0.00179	CbGeAlD
Ruxolitinib—MAP3K2—endocrine gland—alcohol dependence	0.000252	0.00179	CbGeAlD
Ruxolitinib—CAMK2G—liver—alcohol dependence	0.00025	0.00177	CbGeAlD
Ruxolitinib—BMP2K—liver—alcohol dependence	0.00025	0.00177	CbGeAlD
Ruxolitinib—CAMK2G—central nervous system—alcohol dependence	0.00025	0.00177	CbGeAlD
Ruxolitinib—BMP2K—central nervous system—alcohol dependence	0.00025	0.00177	CbGeAlD
Ruxolitinib—STK16—brain—alcohol dependence	0.000249	0.00176	CbGeAlD
Ruxolitinib—LRRK2—liver—alcohol dependence	0.000248	0.00176	CbGeAlD
Ruxolitinib—LRRK2—central nervous system—alcohol dependence	0.000248	0.00176	CbGeAlD
Ruxolitinib—MAP3K3—blood—alcohol dependence	0.000248	0.00176	CbGeAlD
Ruxolitinib—HIPK2—brain—alcohol dependence	0.000248	0.00176	CbGeAlD
Ruxolitinib—TYK2—endocrine gland—alcohol dependence	0.000245	0.00174	CbGeAlD
Ruxolitinib—MAP3K3—midbrain—alcohol dependence	0.000245	0.00173	CbGeAlD
Ruxolitinib—BMP2K—cerebellum—alcohol dependence	0.000245	0.00173	CbGeAlD
Ruxolitinib—CAMK2G—cerebellum—alcohol dependence	0.000245	0.00173	CbGeAlD
Ruxolitinib—MAP3K19—brain—alcohol dependence	0.000243	0.00172	CbGeAlD
Ruxolitinib—LRRK2—cerebellum—alcohol dependence	0.000242	0.00172	CbGeAlD
Ruxolitinib—MKNK2—endocrine gland—alcohol dependence	0.000242	0.00171	CbGeAlD
Ruxolitinib—MAP3K2—testis—alcohol dependence	0.00024	0.0017	CbGeAlD
Ruxolitinib—MAP3K7—testis—alcohol dependence	0.000238	0.00169	CbGeAlD
Ruxolitinib—DAPK3—brain—alcohol dependence	0.000238	0.00169	CbGeAlD
Ruxolitinib—TAOK3—digestive system—alcohol dependence	0.000237	0.00168	CbGeAlD
Ruxolitinib—RET—endocrine gland—alcohol dependence	0.000236	0.00167	CbGeAlD
Ruxolitinib—MAP3K2—nervous system—alcohol dependence	0.000236	0.00167	CbGeAlD
Ruxolitinib—CLK2—brain—alcohol dependence	0.000236	0.00167	CbGeAlD
Ruxolitinib—TYK2—testis—alcohol dependence	0.000234	0.00166	CbGeAlD
Ruxolitinib—MKNK2—testis—alcohol dependence	0.000231	0.00164	CbGeAlD
Ruxolitinib—IRAK1—testis—alcohol dependence	0.000231	0.00164	CbGeAlD
Ruxolitinib—TYK2—nervous system—alcohol dependence	0.00023	0.00163	CbGeAlD
Ruxolitinib—ROCK1—brain—alcohol dependence	0.000229	0.00162	CbGeAlD
Ruxolitinib—MAP3K2—liver—alcohol dependence	0.000227	0.00161	CbGeAlD
Ruxolitinib—MAP3K2—central nervous system—alcohol dependence	0.000227	0.00161	CbGeAlD
Ruxolitinib—MKNK2—nervous system—alcohol dependence	0.000227	0.00161	CbGeAlD
Ruxolitinib—TAOK3—blood—alcohol dependence	0.000226	0.0016	CbGeAlD
Ruxolitinib—MAP3K7—liver—alcohol dependence	0.000225	0.0016	CbGeAlD
Ruxolitinib—RET—testis—alcohol dependence	0.000225	0.0016	CbGeAlD
Ruxolitinib—TAOK3—midbrain—alcohol dependence	0.000223	0.00158	CbGeAlD
Ruxolitinib—JAK2—endocrine gland—alcohol dependence	0.000223	0.00158	CbGeAlD
Ruxolitinib—DYRK1A—brain—alcohol dependence	0.000223	0.00158	CbGeAlD
Ruxolitinib—MAP3K2—cerebellum—alcohol dependence	0.000222	0.00157	CbGeAlD
Ruxolitinib—BMPR2—brain—alcohol dependence	0.000222	0.00157	CbGeAlD
Ruxolitinib—TYK2—liver—alcohol dependence	0.000221	0.00157	CbGeAlD
Ruxolitinib—TYK2—central nervous system—alcohol dependence	0.000221	0.00157	CbGeAlD
Ruxolitinib—RET—nervous system—alcohol dependence	0.000221	0.00157	CbGeAlD
Ruxolitinib—MAP3K7—cerebellum—alcohol dependence	0.00022	0.00156	CbGeAlD
Ruxolitinib—IRAK1—liver—alcohol dependence	0.000218	0.00155	CbGeAlD
Ruxolitinib—MKNK2—liver—alcohol dependence	0.000218	0.00155	CbGeAlD
Ruxolitinib—MKNK2—central nervous system—alcohol dependence	0.000218	0.00155	CbGeAlD
Ruxolitinib—TYK2—cerebellum—alcohol dependence	0.000216	0.00153	CbGeAlD
Ruxolitinib—MAP3K3—endocrine gland—alcohol dependence	0.000215	0.00152	CbGeAlD
Ruxolitinib—MKNK2—cerebellum—alcohol dependence	0.000213	0.00151	CbGeAlD
Ruxolitinib—IRAK1—cerebellum—alcohol dependence	0.000213	0.00151	CbGeAlD
Ruxolitinib—JAK2—testis—alcohol dependence	0.000213	0.00151	CbGeAlD
Ruxolitinib—RET—central nervous system—alcohol dependence	0.000213	0.00151	CbGeAlD
Ruxolitinib—NUAK2—brain—alcohol dependence	0.000212	0.0015	CbGeAlD
Ruxolitinib—JAK2—nervous system—alcohol dependence	0.000209	0.00148	CbGeAlD
Ruxolitinib—RET—cerebellum—alcohol dependence	0.000208	0.00147	CbGeAlD
Ruxolitinib—MAP3K3—testis—alcohol dependence	0.000205	0.00145	CbGeAlD
Ruxolitinib—MAP3K3—nervous system—alcohol dependence	0.000201	0.00143	CbGeAlD
Ruxolitinib—JAK2—liver—alcohol dependence	0.000201	0.00143	CbGeAlD
Ruxolitinib—JAK2—central nervous system—alcohol dependence	0.000201	0.00142	CbGeAlD
Ruxolitinib—CAMK2G—brain—alcohol dependence	0.000199	0.00141	CbGeAlD
Ruxolitinib—BMP2K—brain—alcohol dependence	0.000199	0.00141	CbGeAlD
Ruxolitinib—LRRK2—brain—alcohol dependence	0.000197	0.00139	CbGeAlD
Ruxolitinib—JAK2—cerebellum—alcohol dependence	0.000197	0.00139	CbGeAlD
Ruxolitinib—TAOK3—endocrine gland—alcohol dependence	0.000196	0.00139	CbGeAlD
Ruxolitinib—MAP3K3—liver—alcohol dependence	0.000194	0.00137	CbGeAlD
Ruxolitinib—MAP3K3—central nervous system—alcohol dependence	0.000194	0.00137	CbGeAlD
Ruxolitinib—MAP3K3—cerebellum—alcohol dependence	0.000189	0.00134	CbGeAlD
Ruxolitinib—TAOK3—testis—alcohol dependence	0.000187	0.00132	CbGeAlD
Ruxolitinib—TAOK3—nervous system—alcohol dependence	0.000184	0.0013	CbGeAlD
Ruxolitinib—MAP3K2—brain—alcohol dependence	0.00018	0.00128	CbGeAlD
Ruxolitinib—MAP3K7—brain—alcohol dependence	0.000179	0.00127	CbGeAlD
Ruxolitinib—TAOK3—liver—alcohol dependence	0.000177	0.00125	CbGeAlD
Ruxolitinib—TAOK3—central nervous system—alcohol dependence	0.000177	0.00125	CbGeAlD
Ruxolitinib—TYK2—brain—alcohol dependence	0.000175	0.00124	CbGeAlD
Ruxolitinib—MKNK2—brain—alcohol dependence	0.000173	0.00123	CbGeAlD
Ruxolitinib—IRAK1—brain—alcohol dependence	0.000173	0.00123	CbGeAlD
Ruxolitinib—TAOK3—cerebellum—alcohol dependence	0.000173	0.00122	CbGeAlD
Ruxolitinib—RET—brain—alcohol dependence	0.000169	0.0012	CbGeAlD
Ruxolitinib—JAK2—brain—alcohol dependence	0.00016	0.00113	CbGeAlD
Ruxolitinib—MAP3K3—brain—alcohol dependence	0.000154	0.00109	CbGeAlD
Ruxolitinib—TAOK3—brain—alcohol dependence	0.00014	0.000994	CbGeAlD
Ruxolitinib—CYP3A4—digestive system—alcohol dependence	7.21e-05	0.000511	CbGeAlD
Ruxolitinib—CYP3A4—blood—alcohol dependence	6.87e-05	0.000487	CbGeAlD
Ruxolitinib—CYP3A4—endocrine gland—alcohol dependence	5.96e-05	0.000422	CbGeAlD
Ruxolitinib—CYP3A4—nervous system—alcohol dependence	5.58e-05	0.000395	CbGeAlD
Ruxolitinib—CYP3A4—liver—alcohol dependence	5.37e-05	0.00038	CbGeAlD
Ruxolitinib—CYP3A4—central nervous system—alcohol dependence	5.37e-05	0.00038	CbGeAlD
Ruxolitinib—JAK1—Signaling Pathways—CRHR1—alcohol dependence	3.16e-05	0.000358	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—NPY—alcohol dependence	3.13e-05	0.000356	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—GOT2—alcohol dependence	3.12e-05	0.000355	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—WASF2—alcohol dependence	3.1e-05	0.000352	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CRHR1—alcohol dependence	3.1e-05	0.000352	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—CHRM2—alcohol dependence	3.09e-05	0.000351	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—AVP—alcohol dependence	3.09e-05	0.000351	CbGpPWpGaD
Ruxolitinib—PLK1—Cell Cycle—EP300—alcohol dependence	3.07e-05	0.000349	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—AVP—alcohol dependence	3.04e-05	0.000345	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—WASF1—alcohol dependence	3.03e-05	0.000344	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—HTR1B—alcohol dependence	3.02e-05	0.000343	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—CRH—alcohol dependence	3.02e-05	0.000343	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—HTR2A—alcohol dependence	2.99e-05	0.000339	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CRHR1—alcohol dependence	2.99e-05	0.000339	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—WASF1—alcohol dependence	2.98e-05	0.000338	CbGpPWpGaD
Ruxolitinib—PRKCE—Hemostasis—EP300—alcohol dependence	2.97e-05	0.000337	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CHRM2—alcohol dependence	2.97e-05	0.000337	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—OPRK1—alcohol dependence	2.95e-05	0.000335	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—HTR2A—alcohol dependence	2.93e-05	0.000332	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CHRM2—alcohol dependence	2.92e-05	0.000331	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—NPY—alcohol dependence	2.91e-05	0.000331	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—DRD4—alcohol dependence	2.91e-05	0.000331	CbGpPWpGaD
Ruxolitinib—PLK4—Cell Cycle—EP300—alcohol dependence	2.87e-05	0.000326	CbGpPWpGaD
Ruxolitinib—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	2.84e-05	0.000323	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—OPRM1—alcohol dependence	2.84e-05	0.000323	CbGpPWpGaD
Ruxolitinib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	2.83e-05	0.000321	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—POMC—alcohol dependence	2.83e-05	0.000321	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—HTR1B—alcohol dependence	2.81e-05	0.000319	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CRH—alcohol dependence	2.81e-05	0.000319	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CHRM2—alcohol dependence	2.81e-05	0.000319	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—AVP—alcohol dependence	2.81e-05	0.000319	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—POMC—alcohol dependence	2.79e-05	0.000317	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—CNR1—alcohol dependence	2.78e-05	0.000316	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—AVP—alcohol dependence	2.76e-05	0.000313	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—POMC—alcohol dependence	2.75e-05	0.000312	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—WASF2—alcohol dependence	2.73e-05	0.00031	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—OPRM1—alcohol dependence	2.72e-05	0.000309	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—HTR2A—alcohol dependence	2.71e-05	0.000308	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—DRD2—alcohol dependence	2.71e-05	0.000308	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—HTR7—alcohol dependence	2.71e-05	0.000308	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—GOT1—alcohol dependence	2.7e-05	0.000306	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—OPRD1—alcohol dependence	2.69e-05	0.000306	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—OPRM1—alcohol dependence	2.68e-05	0.000304	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—EP300—alcohol dependence	2.67e-05	0.000304	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—DRD4—alcohol dependence	2.64e-05	0.0003	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—WASF1—alcohol dependence	2.62e-05	0.000297	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—NPY—alcohol dependence	2.61e-05	0.000297	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—OPRD1—alcohol dependence	2.61e-05	0.000297	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—POMC—alcohol dependence	2.58e-05	0.000293	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—PDYN—alcohol dependence	2.58e-05	0.000293	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—OPRM1—alcohol dependence	2.58e-05	0.000293	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—HTR2A—alcohol dependence	2.57e-05	0.000292	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—POMC—alcohol dependence	2.57e-05	0.000292	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—OPRD1—alcohol dependence	2.53e-05	0.000288	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—HTR2A—alcohol dependence	2.53e-05	0.000287	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—CNR1—alcohol dependence	2.52e-05	0.000286	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—CRH—alcohol dependence	2.52e-05	0.000286	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—HTR1B—alcohol dependence	2.52e-05	0.000286	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—NPY—alcohol dependence	2.51e-05	0.000285	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—PDYN—alcohol dependence	2.51e-05	0.000285	CbGpPWpGaD
Ruxolitinib—JAK3—Hemostasis—EP300—alcohol dependence	2.51e-05	0.000285	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—NPY—alcohol dependence	2.47e-05	0.00028	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—HTR7—alcohol dependence	2.46e-05	0.00028	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—DRD2—alcohol dependence	2.46e-05	0.00028	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—DRD4—alcohol dependence	2.46e-05	0.000279	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—EP300—alcohol dependence	2.45e-05	0.000278	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—PDYN—alcohol dependence	2.43e-05	0.000276	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—HTR1B—alcohol dependence	2.42e-05	0.000275	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CRH—alcohol dependence	2.42e-05	0.000275	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CRHR1—alcohol dependence	2.4e-05	0.000273	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—WASF2—alcohol dependence	2.4e-05	0.000273	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—POMC—alcohol dependence	2.39e-05	0.000271	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—HTR1B—alcohol dependence	2.38e-05	0.00027	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CRH—alcohol dependence	2.38e-05	0.00027	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—NPY—alcohol dependence	2.37e-05	0.00027	CbGpPWpGaD
Ruxolitinib—JAK2—Chromatin modifying enzymes—EP300—alcohol dependence	2.37e-05	0.00027	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CNR1—alcohol dependence	2.35e-05	0.000266	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—POMC—alcohol dependence	2.34e-05	0.000265	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—HTR2A—alcohol dependence	2.33e-05	0.000265	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—WASF2—alcohol dependence	2.33e-05	0.000265	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CRHR1—alcohol dependence	2.33e-05	0.000265	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—GOT2—alcohol dependence	2.31e-05	0.000262	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—WASF1—alcohol dependence	2.3e-05	0.000261	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—HTR2A—alcohol dependence	2.3e-05	0.000261	CbGpPWpGaD
Ruxolitinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	2.29e-05	0.00026	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—HTR1B—alcohol dependence	2.29e-05	0.00026	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CRH—alcohol dependence	2.29e-05	0.00026	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—DRD2—alcohol dependence	2.29e-05	0.00026	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—HTR7—alcohol dependence	2.29e-05	0.00026	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—AVP—alcohol dependence	2.28e-05	0.000259	CbGpPWpGaD
Ruxolitinib—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	2.27e-05	0.000258	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CRHR1—alcohol dependence	2.26e-05	0.000257	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—WASF2—alcohol dependence	2.26e-05	0.000257	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CHRM2—alcohol dependence	2.26e-05	0.000256	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling by Wnt—EP300—alcohol dependence	2.24e-05	0.000255	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	2.24e-05	0.000255	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—WASF1—alcohol dependence	2.23e-05	0.000254	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—EP300—alcohol dependence	2.21e-05	0.000251	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—DRD4—alcohol dependence	2.2e-05	0.00025	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—EP300—alcohol dependence	2.2e-05	0.00025	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CHRM2—alcohol dependence	2.19e-05	0.000249	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—EP300—alcohol dependence	2.18e-05	0.000248	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—POMC—alcohol dependence	2.17e-05	0.000246	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—WASF1—alcohol dependence	2.17e-05	0.000246	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—EP300—alcohol dependence	2.16e-05	0.000245	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—EP300—alcohol dependence	2.16e-05	0.000245	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CHRM2—alcohol dependence	2.12e-05	0.000241	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—DRD4—alcohol dependence	2.11e-05	0.00024	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—CNR1—alcohol dependence	2.11e-05	0.000239	CbGpPWpGaD
Ruxolitinib—CYP3A4—Biological oxidations—GGT1—alcohol dependence	2.09e-05	0.000237	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—DRD4—alcohol dependence	2.08e-05	0.000236	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—AVP—alcohol dependence	2.07e-05	0.000235	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—OPRM1—alcohol dependence	2.07e-05	0.000235	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—HTR7—alcohol dependence	2.05e-05	0.000233	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—DRD2—alcohol dependence	2.05e-05	0.000233	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—POMC—alcohol dependence	2.05e-05	0.000233	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—POMC—alcohol dependence	2.02e-05	0.000229	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CNR1—alcohol dependence	2.02e-05	0.000229	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—OPRM1—alcohol dependence	2.01e-05	0.000228	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—DRD4—alcohol dependence	2e-05	0.000227	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—GOT1—alcohol dependence	1.99e-05	0.000226	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CNR1—alcohol dependence	1.99e-05	0.000225	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—OPRD1—alcohol dependence	1.98e-05	0.000225	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—DRD2—alcohol dependence	1.97e-05	0.000224	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—HTR7—alcohol dependence	1.97e-05	0.000224	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—OPRM1—alcohol dependence	1.95e-05	0.000222	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—EP300—alcohol dependence	1.94e-05	0.00022	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—DRD2—alcohol dependence	1.94e-05	0.00022	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—HTR7—alcohol dependence	1.94e-05	0.00022	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—AVP—alcohol dependence	1.93e-05	0.000219	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CNR1—alcohol dependence	1.91e-05	0.000217	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NPY—alcohol dependence	1.91e-05	0.000217	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—HTR2A—alcohol dependence	1.9e-05	0.000216	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PDYN—alcohol dependence	1.9e-05	0.000216	CbGpPWpGaD
Ruxolitinib—CYP3A4—Biological oxidations—MAOA—alcohol dependence	1.87e-05	0.000212	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—DRD2—alcohol dependence	1.87e-05	0.000212	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—HTR7—alcohol dependence	1.87e-05	0.000212	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—POMC—alcohol dependence	1.86e-05	0.000212	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—EP300—alcohol dependence	1.85e-05	0.000211	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NPY—alcohol dependence	1.85e-05	0.00021	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—HTR1B—alcohol dependence	1.84e-05	0.000209	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CRH—alcohol dependence	1.84e-05	0.000209	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—POMC—alcohol dependence	1.83e-05	0.000208	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—EP300—alcohol dependence	1.82e-05	0.000207	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NPY—alcohol dependence	1.79e-05	0.000204	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—HTR1B—alcohol dependence	1.79e-05	0.000203	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CRH—alcohol dependence	1.79e-05	0.000203	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CRHR1—alcohol dependence	1.77e-05	0.000201	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—WASF2—alcohol dependence	1.77e-05	0.000201	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—GOT2—alcohol dependence	1.75e-05	0.000198	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—HTR1B—alcohol dependence	1.73e-05	0.000197	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CRH—alcohol dependence	1.73e-05	0.000197	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—AVP—alcohol dependence	1.73e-05	0.000196	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—HTR2A—alcohol dependence	1.72e-05	0.000196	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—EP300—alcohol dependence	1.71e-05	0.000195	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—WASF1—alcohol dependence	1.69e-05	0.000192	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CHRM2—alcohol dependence	1.66e-05	0.000189	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—AVP—alcohol dependence	1.66e-05	0.000188	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—AVP—alcohol dependence	1.63e-05	0.000185	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—EP300—alcohol dependence	1.62e-05	0.000184	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—DRD4—alcohol dependence	1.61e-05	0.000183	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—HTR2A—alcohol dependence	1.6e-05	0.000182	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—AVP—alcohol dependence	1.57e-05	0.000178	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—DRD4—alcohol dependence	1.56e-05	0.000177	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—EP300—alcohol dependence	1.56e-05	0.000177	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—EP300—alcohol dependence	1.55e-05	0.000176	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CNR1—alcohol dependence	1.53e-05	0.000174	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—OPRM1—alcohol dependence	1.52e-05	0.000173	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—POMC—alcohol dependence	1.52e-05	0.000172	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—DRD4—alcohol dependence	1.51e-05	0.000172	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—GOT1—alcohol dependence	1.51e-05	0.000171	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—HTR7—alcohol dependence	1.5e-05	0.00017	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—DRD2—alcohol dependence	1.5e-05	0.00017	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CNR1—alcohol dependence	1.49e-05	0.000169	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—EP300—alcohol dependence	1.48e-05	0.000168	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—DRD2—alcohol dependence	1.45e-05	0.000165	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—HTR7—alcohol dependence	1.45e-05	0.000165	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CNR1—alcohol dependence	1.45e-05	0.000164	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—HTR2A—alcohol dependence	1.44e-05	0.000163	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—EP300—alcohol dependence	1.44e-05	0.000163	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—EP300—alcohol dependence	1.43e-05	0.000163	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—EP300—alcohol dependence	1.43e-05	0.000162	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—HTR7—alcohol dependence	1.41e-05	0.00016	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—DRD2—alcohol dependence	1.41e-05	0.00016	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NPY—alcohol dependence	1.4e-05	0.000159	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—EP300—alcohol dependence	1.39e-05	0.000158	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—EP300—alcohol dependence	1.39e-05	0.000158	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—HTR2A—alcohol dependence	1.38e-05	0.000157	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—POMC—alcohol dependence	1.38e-05	0.000156	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—HTR2A—alcohol dependence	1.36e-05	0.000154	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CRH—alcohol dependence	1.35e-05	0.000154	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—HTR1B—alcohol dependence	1.35e-05	0.000154	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ADH6—alcohol dependence	1.31e-05	0.000149	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—EP300—alcohol dependence	1.31e-05	0.000149	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—HTR2A—alcohol dependence	1.31e-05	0.000148	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—POMC—alcohol dependence	1.28e-05	0.000145	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—AVP—alcohol dependence	1.26e-05	0.000143	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—EP300—alcohol dependence	1.23e-05	0.00014	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—AVP—alcohol dependence	1.22e-05	0.000139	CbGpPWpGaD
Ruxolitinib—CYP3A4—Biological oxidations—POMC—alcohol dependence	1.22e-05	0.000138	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—EP300—alcohol dependence	1.21e-05	0.000137	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—AVP—alcohol dependence	1.19e-05	0.000135	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—DRD4—alcohol dependence	1.18e-05	0.000134	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—POMC—alcohol dependence	1.15e-05	0.00013	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—EP300—alcohol dependence	1.13e-05	0.000128	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CNR1—alcohol dependence	1.13e-05	0.000128	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—HTR7—alcohol dependence	1.1e-05	0.000125	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—DRD2—alcohol dependence	1.1e-05	0.000125	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—POMC—alcohol dependence	1.1e-05	0.000125	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ADH1A—alcohol dependence	1.09e-05	0.000124	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—EP300—alcohol dependence	1.09e-05	0.000123	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—POMC—alcohol dependence	1.08e-05	0.000123	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—HTR2A—alcohol dependence	1.05e-05	0.000119	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—EP300—alcohol dependence	1.04e-05	0.000119	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—POMC—alcohol dependence	1.04e-05	0.000118	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—HTR2A—alcohol dependence	1.02e-05	0.000116	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—EP300—alcohol dependence	1.01e-05	0.000114	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—HTR2A—alcohol dependence	9.88e-06	0.000112	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—AVP—alcohol dependence	9.27e-06	0.000105	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ADH4—alcohol dependence	9.26e-06	0.000105	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—EP300—alcohol dependence	8.59e-06	9.76e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—EP300—alcohol dependence	8.49e-06	9.65e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—POMC—alcohol dependence	8.38e-06	9.51e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—EP300—alcohol dependence	8.34e-06	9.48e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—POMC—alcohol dependence	8.13e-06	9.24e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—EP300—alcohol dependence	8.09e-06	9.19e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—POMC—alcohol dependence	7.89e-06	8.96e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ADH7—alcohol dependence	7.87e-06	8.94e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—HTR2A—alcohol dependence	7.72e-06	8.76e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—EP300—alcohol dependence	7.7e-06	8.75e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GGT2—alcohol dependence	7.55e-06	8.57e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—EP300—alcohol dependence	7.31e-06	8.3e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—EP300—alcohol dependence	7.19e-06	8.16e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ADH1B—alcohol dependence	6.9e-06	7.84e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—EP300—alcohol dependence	6.32e-06	7.18e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—POMC—alcohol dependence	6.16e-06	7e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—EP300—alcohol dependence	5.84e-06	6.63e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—MAOB—alcohol dependence	5.72e-06	6.5e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—EP300—alcohol dependence	5.56e-06	6.31e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—EP300—alcohol dependence	5.39e-06	6.13e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—EP300—alcohol dependence	5.23e-06	5.94e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ALDH2—alcohol dependence	4.86e-06	5.52e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GOT2—alcohol dependence	4.14e-06	4.7e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—EP300—alcohol dependence	4.09e-06	4.64e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CYP2E1—alcohol dependence	3.89e-06	4.42e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GOT1—alcohol dependence	3.57e-06	4.06e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GGT1—alcohol dependence	3.57e-06	4.06e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—MAOA—alcohol dependence	3.2e-06	3.63e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—POMC—alcohol dependence	2.08e-06	2.37e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—EP300—alcohol dependence	1.38e-06	1.57e-05	CbGpPWpGaD
